Van Berkel T J, Van Velzen A, Kruijt J K, Suzuki H, Kodama T
Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Sylvius Laboratory, University of Leiden, P.O. Box 9503, 2300 RA Leiden, The Netherlands.
Biochem J. 1998 Apr 1;331 ( Pt 1)(Pt 1):29-35. doi: 10.1042/bj3310029.
The liver is the major organ responsible for the uptake of modified low-density lipoprotein (LDL) from the blood circulation, with endothelial and Kupffer cells as major cellular uptake sites. Scavenger-receptors, which include various classes, are held responsible for this uptake. Mice deficient in scavenger-receptor class A types I and II were created and the fate of acetylated LDL (Ac-LDL) in vivo and its interaction with liver endothelial, Kupffer and peritoneal macrophages was characterized. Surprisingly, the decay in vivo (t12 < 2 min), tissue distribution and liver uptake (at 5 min it was 77.4 +/- 4.6% of the injected dose) of Ac-LDL in the knock-out mice were not significantly different from control mice (t12 < 2 min and liver uptake 79.1 +/- 4.6% of the injected dose). A separation of mice liver cells into parenchymal, endothelial and Kupffer cells 10 min after injection of Ac-LDL indicated that in both control and knock-out mice the liver endothelial cells were responsible for more than 70% of the liver uptake. Both in control and knock-out mice, preinjection of polyinosinic acid (poly I, 200 microg) completely blocked the liver uptake, indicating that both in control and knock-out mice the scavenger-receptors are sensitive to poly I. Preinjection of suboptimal poly I concentrations (20 and 50 microg) provided evidence that the serum decay and liver uptake of Ac-LDL is more readily inhibited in the knock-out mice as compared with the control mice, indicating less efficient removal of Ac-LDL in vivo in the knock-out mice under these conditions. Studies in vitro with isolated liver endothelial and Kupffer cells from knock-out mice indicate that the cell association of Ac-LDL during 2 h at 37 degrees C is 50 and 53% of the control, respectively, whereas the degradation reaches values of 58 and 63%. For peritoneal macrophages from knock-out mice the cell association of Ac-LDL was identical to the control mice whereas the Ac-LDL degradation in cells from the knock-out mice was 17% of the control. The low degradation capacity of peritoneal macrophages from knock-out mice for Ac-LDL indicates that scavenger-receptor class A types I and II play a quantitative important role in the degradation of Ac-LDL by macrophages. In liver, the contribution of scavenger-receptor class A types I and II to the maximal uptake and degradation of Ac-LDL by endothelial and Kupffer cells was 40-50%. Binding studies performed at 4 degrees C indicate that the lower rates of degradation are due to a lower number of surface receptors on the cells from the knock-out mice. From the in vitro and in vivo data it can be concluded that in addition to the classic scavenger-receptors class A types I and II liver does contain additional novel poly I-sensitive scavenger-receptors that facilitate efficient removal of Ac-LDL from the blood circulation. The availability of the scavenger-receptor class A types I and II knock-out mice will stimulate further molecular identification of these receptors.
肝脏是负责从血液循环中摄取修饰型低密度脂蛋白(LDL)的主要器官,内皮细胞和库普弗细胞是主要的细胞摄取部位。包括多种类型的清道夫受体负责这种摄取。构建了缺乏A类清道夫受体I型和II型的小鼠,并对体内乙酰化LDL(Ac-LDL)的命运及其与肝内皮细胞、库普弗细胞和腹膜巨噬细胞的相互作用进行了表征。令人惊讶的是,敲除小鼠体内Ac-LDL的体内衰变(t1/2<2分钟)、组织分布和肝脏摄取(5分钟时为注射剂量的77.4±4.6%)与对照小鼠无显著差异(t1/2<2分钟,肝脏摄取为注射剂量的79.1±4.6%)。注射Ac-LDL 10分钟后将小鼠肝细胞分离为实质细胞、内皮细胞和库普弗细胞,结果表明,在对照小鼠和敲除小鼠中,肝内皮细胞均负责超过70%的肝脏摄取。在对照小鼠和敲除小鼠中,预先注射多聚肌苷酸(聚I,200微克)均可完全阻断肝脏摄取,这表明在对照小鼠和敲除小鼠中,清道夫受体均对聚I敏感。预先注射次优浓度的聚I(20和50微克)表明,与对照小鼠相比,敲除小鼠中Ac-LDL的血清衰变和肝脏摄取更容易受到抑制,这表明在这些条件下敲除小鼠体内Ac-LDL的清除效率较低。对敲除小鼠分离的肝内皮细胞和库普弗细胞进行的体外研究表明,在37℃下2小时内Ac-LDL与细胞的结合分别为对照的50%和53%,而降解率分别为58%和63%。对于敲除小鼠的腹膜巨噬细胞,Ac-LDL与细胞的结合与对照小鼠相同,而敲除小鼠细胞中Ac-LDL的降解为对照的17%。敲除小鼠的腹膜巨噬细胞对Ac-LDL的低降解能力表明,A类清道夫受体I型和II型在巨噬细胞对Ac-LDL的降解中起重要的定量作用。在肝脏中,A类清道夫受体I型和II型对内皮细胞和库普弗细胞对Ac-LDL的最大摄取和降解的贡献为40-50%。在4℃下进行的结合研究表明,较低的降解率是由于敲除小鼠细胞表面受体数量较少。从体外和体内数据可以得出结论,除了经典的A类清道夫受体I型和II型外,肝脏确实还含有其他新型的对聚I敏感的清道夫受体,这些受体有助于从血液循环中有效清除Ac-LDL。A类清道夫受体I型和II型敲除小鼠的可得性将刺激对这些受体的进一步分子鉴定。